ZA983852B - Therapy for constipation - Google Patents
Therapy for constipationInfo
- Publication number
- ZA983852B ZA983852B ZA983852A ZA983852A ZA983852B ZA 983852 B ZA983852 B ZA 983852B ZA 983852 A ZA983852 A ZA 983852A ZA 983852 A ZA983852 A ZA 983852A ZA 983852 B ZA983852 B ZA 983852B
- Authority
- ZA
- South Africa
- Prior art keywords
- constipation
- therapy
- Prior art date
Links
- 206010010774 Constipation Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO6653A AUPO665397A0 (en) | 1997-05-07 | 1997-05-07 | Novel therapy for constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA983852B true ZA983852B (en) | 1998-11-13 |
Family
ID=3800945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA983852A ZA983852B (en) | 1997-05-07 | 1998-05-07 | Therapy for constipation |
Country Status (13)
Country | Link |
---|---|
US (1) | US6426338B1 (de) |
EP (1) | EP0980246B1 (de) |
AR (1) | AR012671A1 (de) |
AT (1) | ATE349216T1 (de) |
AU (1) | AUPO665397A0 (de) |
CA (1) | CA2289717C (de) |
CY (1) | CY1107586T1 (de) |
DE (1) | DE69836735T2 (de) |
DK (1) | DK0980246T3 (de) |
ES (1) | ES2279573T3 (de) |
PT (1) | PT980246E (de) |
WO (1) | WO1998050043A1 (de) |
ZA (1) | ZA983852B (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE448194T1 (de) * | 2000-08-29 | 2009-11-15 | Biocon Ltd | Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts |
US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
US7025745B2 (en) * | 2002-10-07 | 2006-04-11 | Advanced Cardiovascular Systems, Inc. | Method of making a catheter balloon using a tapered mandrel |
DE10257824B4 (de) * | 2002-12-10 | 2004-11-11 | Kochem, Hans-Günter, Dr. | Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen |
US20050075395A1 (en) * | 2003-05-28 | 2005-04-07 | Gary Gordon | Continuous dosing regimen |
US20040242649A1 (en) * | 2003-05-29 | 2004-12-02 | Hagey Anne E. | Extended dosing regimen |
JP2007500240A (ja) * | 2003-05-29 | 2007-01-11 | アボット・ラボラトリーズ | Abt−751による持続投与レジメン |
ATE554752T1 (de) * | 2004-02-06 | 2012-05-15 | Pharmatel R & D Pty Ltd As Trustee For The Pharmatel R & D Trust | Verwendung von aminosalicylaten beim reizdarmsyndrom mit durchfall als vorherrschendem symptom |
US20050191371A1 (en) * | 2004-02-12 | 2005-09-01 | Rizo Andres M. | Medical composition |
US20080306029A1 (en) * | 2004-05-28 | 2008-12-11 | Salix Pharmaceuticals, Inc. | Prevention, Treatment, and Amelioration of Radiation Induced Enteritis |
WO2006014549A2 (en) | 2004-07-07 | 2006-02-09 | Nobex Corporation | Synthesis of azo bonded immunoregulatory compounds |
US7452872B2 (en) * | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
CN103948609A (zh) * | 2005-08-24 | 2014-07-30 | 萨利克斯药品公司 | 巴柳氮制剂及其生产和应用 |
PL2493471T3 (pl) | 2009-10-26 | 2020-10-19 | Borody | Nowa skojarzona terapia jelitowa |
US9629881B2 (en) | 2010-02-01 | 2017-04-25 | Rebiotix, Inc. | Bacteriotherapy for clostridium difficile colitis |
JP2013525440A (ja) | 2010-04-26 | 2013-06-20 | サリックス ファーマシューティカルズ リミテッド | 男性の治療のための2−ヒドロキシ−5−フェニルアゾ安息香酸誘導体の製剤および使用 |
PL2651415T3 (pl) | 2010-12-13 | 2021-04-19 | Rite-Prep Pty Ltd. | Formulacje dożołądkowe i dookrężnicze oraz sposoby ich wytwarzania i zastosowania |
JP2015514715A (ja) * | 2012-03-30 | 2015-05-21 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | コルヒチン製剤、その製造方法および使用方法 |
HUE043852T2 (hu) | 2012-07-27 | 2019-09-30 | Redhill Biopharma Ltd | A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei |
AU2014275025B2 (en) | 2013-06-05 | 2016-12-01 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
KR102342925B1 (ko) | 2015-06-09 | 2021-12-23 | 리바이오틱스, 인코퍼레이티드 | 미생물상 복원 치료(mrt) 조성물 및 제조 방법 |
US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5519014A (en) * | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
ATE256468T1 (de) * | 1990-10-22 | 2004-01-15 | Gastro Services Pty Ltd | Behandlung von nicht-entzündlichen darmerkrankungen |
-
1997
- 1997-05-07 AU AUPO6653A patent/AUPO665397A0/en not_active Abandoned
-
1998
- 1998-05-07 PT PT98918987T patent/PT980246E/pt unknown
- 1998-05-07 EP EP98918987A patent/EP0980246B1/de not_active Expired - Lifetime
- 1998-05-07 ZA ZA983852A patent/ZA983852B/xx unknown
- 1998-05-07 DE DE69836735T patent/DE69836735T2/de not_active Expired - Lifetime
- 1998-05-07 AT AT98918987T patent/ATE349216T1/de active
- 1998-05-07 CA CA002289717A patent/CA2289717C/en not_active Expired - Lifetime
- 1998-05-07 US US09/403,780 patent/US6426338B1/en not_active Expired - Lifetime
- 1998-05-07 AR ARP980102128A patent/AR012671A1/es unknown
- 1998-05-07 DK DK98918987T patent/DK0980246T3/da active
- 1998-05-07 ES ES98918987T patent/ES2279573T3/es not_active Expired - Lifetime
- 1998-05-07 WO PCT/AU1998/000332 patent/WO1998050043A1/en active IP Right Grant
-
2007
- 2007-03-20 CY CY20071100396T patent/CY1107586T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2289717A1 (en) | 1998-11-12 |
EP0980246A4 (de) | 2004-04-14 |
ES2279573T3 (es) | 2007-08-16 |
AR012671A1 (es) | 2000-11-08 |
DE69836735T2 (de) | 2007-10-11 |
PT980246E (pt) | 2007-02-28 |
CA2289717C (en) | 2009-02-03 |
ATE349216T1 (de) | 2007-01-15 |
WO1998050043A1 (en) | 1998-11-12 |
US6426338B1 (en) | 2002-07-30 |
EP0980246A1 (de) | 2000-02-23 |
CY1107586T1 (el) | 2013-03-13 |
DE69836735D1 (de) | 2007-02-08 |
AUPO665397A0 (en) | 1997-05-29 |
DK0980246T3 (da) | 2007-05-07 |
EP0980246B1 (de) | 2006-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA983852B (en) | Therapy for constipation | |
EG24678A (en) | Combination therapy | |
ZA983176B (en) | Therapeutic compounds | |
GB9725782D0 (en) | Therapeutic agents | |
GB9708484D0 (en) | Therapeutic agents | |
GB9708945D0 (en) | Therapeutic agents | |
GB9704948D0 (en) | Therapeutic agents | |
GB9702524D0 (en) | Therapeutic agents | |
IL127306A0 (en) | Combination therapy | |
GB9711753D0 (en) | Therapeutic agents | |
GB9713707D0 (en) | Therapeutic agents | |
GB9715977D0 (en) | Therapeutic agents | |
GB9711114D0 (en) | Therapeutic agents | |
HUP0300615A3 (en) | Therapeutic agents | |
GB9700939D0 (en) | Therapy | |
GB9702392D0 (en) | Therapeutic agents | |
GB9716345D0 (en) | Therapeutic compounds | |
GB9716347D0 (en) | Therapeutic compounds | |
GB9716344D0 (en) | Therapeutic compounds | |
GB9716463D0 (en) | Therapeutic agents | |
GB9708698D0 (en) | Materials for therapy | |
GB9716457D0 (en) | Therapeutic agents | |
GB9704885D0 (en) | Therapy | |
GB9705401D0 (en) | Therapeutic compounds | |
GB9716111D0 (en) | Therapeutic compounds |